Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2006-3817
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Cross-site scripting (XSS) vulnerability in Novell GroupWise WebAccess 6.5 and 7 before 20060727 allows remote attackers to inject arbitrary web script or HTML via an encoded SCRIPT element in an e-mail message with the UTF-7 character set, as demonstrated by the "+ADw-SCRIPT+AD4-" sequence.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
Novell GroupWise WebAccess 和Novell GroupWise WebAccess 跨站脚本攻击(XSS)漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
20060727之前的Novell GroupWise WebAccess 6.5和Novell GroupWise WebAccess 7版本中具有跨站脚本攻击(XSS)漏洞,远程攻击者可借助带有UTF-7字符集的邮件消息中的编码SCRIPT元素来注入任意web脚本或HTML,如通过"+ADw-SCRIPT+AD4-"序列。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2006-3817
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2006-3817
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2006-3817

No comments yet


Leave a comment